[NBIX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
13-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 161.97%
YoY- 115.44%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 247,900 244,100 131,492 94,517 0 0 0 -
PBT 41,700 38,600 18,808 6,894 -44,659 -29,315 -19,444 -
Tax -306,200 4,600 730 6,686 -2,024 -1,692 -1,233 150.50%
NP 347,900 34,000 18,078 6,894 -44,659 -29,315 -19,444 -
Tax Rate 734.29% -11.92% -3.88% -96.98% - - - -
Total Cost -100,000 210,100 113,414 87,623 44,659 29,315 19,444 -
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 140.34 13.93 13.75 7.29 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 3.72 0.37 0.20 0.08 -0.51 -0.34 -0.26 -
EPS Diluted 3.58 0.35 0.19 0.07 -0.51 -0.34 -0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.